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Abstract 
Acceptance of cancer has long been recognized as playing a critical role in psychological 
adjustment to the illness, but its associations with distress outcomes have not been 
quantitatively reviewed.  Informed by coping theory and third wave conceptualizations of 
acceptance, we first propose an integrated model of acceptance of cancer.  Then we examine 
the strength of the relationships between acceptance of cancer and general and cancer-specific 
distress in cancer patients and potential moderators of these relationships.  CINAHL, Embase, 
MEDLINE, PsycINFO, PsycARTICLES, and Web of Science databases were searched.  
Random-effects meta-analyses were conducted on 78 records (N=15,448).  Small-to-
moderate, negative, and significant relationships were found between acceptance of cancer 
and general distress (r=-.31; 95% CI:-.36 to -.26, k=75); cancer-specific distress (r=-.18; 95% 
CI:-.21 to -.14, k=13); depressive symptoms (r=-.25; 95% CI:-.31 to -.19, k=41); and anxiety 
symptoms (r=-.22; 95% CI:-.30 to -.15, k=29).  Age, marital status, and stage of cancer were 
identified as significant moderators.  Findings suggest that acceptance of cancer may be 
important to target in interventions to reduce general and cancer-specific distress in cancer 
patients.  Future research should focus on developing multifaceted measures of acceptance 
and identifying theory-based psychological and social processes that lead to greater 
acceptance. 
Keywords: cancer; acceptance; depressive symptoms; anxiety; psychological distress; meta-
analysis   
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Introduction 
When diagnosed with a life-threatening disease such as cancer, patients are confronted 
with a range of distressing circumstances (Giese-Davis et al., 2012).  Many cancer patients 
endure aggressive treatments that result in high symptom burden and functional limitations as 
well as financial difficulties (Cleeland et al., 2013; Peppercorn, 2014).  Early-stage cancer 
patients cope with uncertainties about the future, given their risk of recurrence and metastasis 
(Dinkel, Kremsreiter, Marten-Mittag, & Lahmann, 2014).  In comparison, at the advanced 
stages of cancer, patients often face the reality of a limited life expectancy, complex medical 
decision-making, and end-of-life planning (Jaiswal, Alici, & Breitbart, 2014; S. T. Tang et al., 
2014).  Not surprisingly, as many as 40% of cancer patients suffer from mood disorders or 
clinically elevated levels of distress, including increased anxiety and depressive symptoms 
(Caruso, Nanni, Riba, Sabato, & Grassi, 2017; Linden, Vodermaier, MacKenzie, & Greig, 
2012; Mitchell et al., 2011), and up to 80% of patients experience symptoms of cancer-
specific distress (i.e., cancer-related post-traumatic stress disorder [PTSD] or fear of 
recurrence) (Abbey, Thompson, Hickish, & Heathcote, 2015; Caruso et al., 2017; Dinkel et 
al., 2014; van den Beuken-van Everdingen et al., 2008).  Among cancer patients, higher levels 
of distress have been associated with reduced quality of life (L. F. Brown, Kroenke, 
Theobald, Wu, & Tu, 2010; Koch et al., 2014), poor medication and treatment adherence 
(Lin, Clark, Tu, Bosworth, & Zullig, 2017; Mausbach, Schwab, & Irwin, 2015), and poor 
physical health outcomes such as greater symptoms of pain, fatigue, nausea, and sleep 
difficulties (L. F. Brown et al., 2010; Pinquart & Duberstein, 2010; van den Beuken-van 
Everdingen et al., 2008).  Further, depressive symptoms have been associated with lower 
survival rates following a cancer diagnosis (Pinquart & Duberstein, 2010; Satin, Linden, & 
Phillips, 2009).   
Acceptance of Cancer  
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Acceptance of cancer, or making peace with the disease, is one factor that may play an 
important role in reducing patients’ distress.  Acceptance of illness has been conceptualized in 
multiple ways.  Initially, acceptance of illness was defined as a process of value change by 
which the patient accepts the losses related to the illness while maintaining a sense of self-
worth (Wright, 1983).  This process may involve exploring new meanings or possibilities in 
life based on one’s existing values and strengths (Wright, 1983).  Later, acceptance was 
defined as a willingness to be present with one’s illness-related thoughts, feelings, and bodily 
sensations without judging or making unnecessary attempts to control them (Hayes, Jacobson, 
Follette, & Dougher, 1994).  Similarly, McCracken and Eccleston (2003) described 
acceptance as a realistic way of living with illness; that is, an accepting patient does not judge, 
avoid, or deny the illness, but continues feasible engagement in everyday activities.  
Acceptance differs from resignation (i.e., fatalism).  For cancer patients, resignation 
refers to considering the illness as fate and believing that there is little or nothing one can do 
to change or control the illness, its symptoms, and one’s quality of life (Livneh, 2000).  In 
other words, resignation refers to giving up and no longer striving for a fulfilling life—
choosing instead to remain helpless, hopeless, and passive.  Although some researchers have 
considered acceptance and resignation as part of the same process (Barata et al., 2018; Wells, 
Booth-Jones, & Jacobsen, 2009), others have argued that resignation is the opposite of 
acceptance (J. C. Williams & Lynn, 2010; Wright, 1983).  In line with this view, research 
suggests that acceptance is associated with lower anxiety and depressive symptoms (e.g., 
Bussell & Naus, 2010; Peters, Goedendorp, Verhagen, van der Graaf, & Bleijenberg, 2014), 
whereas resignation is associated with higher anxiety and depressive symptoms (Andreu et 
al., 2012; Hong, Wei, & Wang, 2015).  In this review, resignation is excluded, as it appears to 
be a different process with a distinct relation to psychological distress. 
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Acceptance also differs from a fighting spirit.  In the context of cancer, having a 
fighting spirit involves viewing the illness as a challenge, maintaining an optimistic outlook, 
and working towards beating the disease (Livneh, 2000; Watson et al., 1988).  Although both 
acceptance and having a fighting spirit involve taking an active stance, acceptance does not 
necessarily include efforts of positive reframing or aiming to change the course of the disease.  
We contend that acceptance of cancer might be closely linked with having a fighting spirit, 
but only when it is in line with patients’ value systems and the realities of their illness.  
Further, associations between having a fighting spirit and distress are mixed (e.g., Gillanders, 
Sinclair, MacLean, & Jardine, 2015; Watson & Homewood, 2008).  Among advanced cancer 
patients in particular, endorsing a fighting spirit has been associated with greater 
psychological distress (Rand et al., 2016).  Thus, the concept of a fighting spirit was excluded 
from this review. 
Theoretical framework.  The acceptance literature is grounded in multiple theories 
(Carver, Scheier, & Weintraub, 1989; Hayes et al., 1994; Kabat-Zinn, 1990; Lazarus & 
Folkman, 1984; Linehan, 1993; Park, 2010).  In this review, we focus on the most prominent 
theories: coping theory and third wave cognitive-behavioral therapy approaches.  We then 
propose an integrated model of acceptance based on these theories.    
Coping theory.  Coping theory posits that when confronted with significant stressors 
such as cancer, people evaluate the situation with regard to its impact on their lives (i.e., 
primary appraisals), and what, if anything, might be done about it (i.e., secondary appraisals)  
(Lazarus & Folkman, 1984).  Based on their appraisals, people employ various cognitive and 
behavioral efforts (i.e., coping strategies) to manage the demands (Lazarus & Folkman, 
1984).  In a cancer context, acceptance is emotion-focused coping that involves 
acknowledging the reality of the illness, learning to live with it, and engaging in attempts to 
address it (Carver et al., 1989).  Acceptance coping may also involve maintaining an empathic 
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attitude toward oneself (i.e., self-compassion) or expressing feelings about the illness 
experience to others (Sirois, Molnar, & Hirsch, 2015; J. C. Williams, 2007; J. C. Williams & 
Lynn, 2010).   
Another aspect of acceptance coping is developing a sense of meaning in life that 
broadens one’s focus beyond the illness (Threader & McCormack, 2016).  According to 
Park’s (2010) integrated meaning-making model, acceptance is conceptualized as meanings 
made, that is, coming to terms with the illness as a result of meaning-making processes.  For 
example, meanings made may include identifying benefits in the illness experience (i.e., 
benefit finding) or experiencing positive life changes as a result of the illness experience (i.e., 
post-traumatic growth) (Manne et al., 2018; Park, 2010; Sears, Stanton, & Danoff-Burg, 
2003).  However, in line with third wave approaches (Fletcher & Hayes, 2005), acceptance 
can also be conceptualized as a process or a part of ongoing meaning-making efforts.     
Third wave approaches.  An alternative conceptualization of acceptance comes from 
theories underlying third wave cognitive-behavioral therapies, such as Acceptance and 
Commitment Therapy (ACT: Hayes, Strosahl, & Wilson, 1999), Dialectical Behavioral 
Therapy (DBT: Linehan, 1993), mindfulness-based interventions (e.g., Mindfulness-Based 
Stress Reduction [MBSR]: Kabat-Zinn, 1990; Mindfulness-Based Cognitive Therapy 
[MBCT]: Segal, Williams, & Teasdale, 2002), as well as theories of mindfulness (e.g., 
Mindfulness-to-Meaning Theory: Garland, Farb, Goldin, & Fredrickson, 2015; Monitor and 
Acceptance Theory: Lindsay & Creswell, 2017).  According to this conceptualization, 
acceptance involves active awareness of the present moment, including unwanted thoughts, 
feelings, and bodily sensations, without unnecessary attempts to change these experiences 
(i.e., “allowing things to be as they already are” Segal et al., 2002, p. 271) .  From an ACT 
perspective, acceptance contributes to the development of psychological flexibility, which 
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involves maintaining full awareness of the present moment while persisting in actions aligned 
with personal values (Hayes, Luoma, Bond, Masuda, & Lillis, 2006).   
According to third wave theorists, acceptance of cancer involves a non-judgmental 
stance and willingness to experience the realities of the disease, such as symptoms, physical 
decline, and living with uncertainty (Fashler, Weinrib, Azam, & Katz, 2018; Hayes, Follette, 
& Linehan, 2004; Hulbert‐ Williams, Storey, & Wilson, 2015).  These theorists contend that 
acceptance is not simply tolerating the existence of cancer, but, rather, embracing the 
moment-by-moment experience of the illness including the difficult private events (e.g., 
thoughts, feelings, bodily sensations) as they occur (Hayes et al., 2004).  This willingness to 
experience the events without defense has been referred to as experiential acceptance (Hayes 
et al., 1994; Karekla & Panayiotou, 2011; Kashdan, Barrios, Forsyth, & Steger, 2006; J. C. 
Williams & Lynn, 2010).  For some patients, acceptance may involve shifting from 
heightened emotional reactivity to cancer-related thoughts to a stance that reduces this 
struggle (i.e., cognitive defusion).  Third wave theorists also contend that experiential 
acceptance is the opposite of experiential avoidance, defined as attempts or desires to avoid 
unwanted private events, such as thoughts, feelings, and symptoms (Hayes et al., 2004; 
Hulbert‐ Williams et al., 2015; Kashdan et al., 2006).  For example, a cancer patient may 
withdraw from meaningful social activities in order to avoid exacerbations of pain or fatigue 
and, as a consequence, may experience increased loneliness and distress.  Conversely, 
experiential acceptance of cancer may lead to growth in self-compassion, courage, and value-
based living, which are theoretically linked to increased psychological flexibility and better 
psychological well-being (Hayes et al., 1994; Lindsay, Chin, et al., 2018; J. C. Williams, 
2007).   
In third wave theories, acceptance is closely related to mindfulness, defined as an open 
and nonjudgmental awareness of one’s experiences in the present moment (Kabat-Zinn, 
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1994).  Indeed, some theorists conceptualize acceptance as an aspect of mindfulness (Baer, 
Smith, & Allen, 2004; Lindsay & Creswell, 2017).  For example, in their Monitor and 
Acceptance Theory, Lindsay and Creswell (2017) posited that acceptance and attention 
monitoring are the two main components of mindfulness.  Thus, acceptance is defined as a 
“dynamic emotion regulation skill,” which, in the context of cancer, may lead to reduced 
emotional reactivity and reappraisal of cancer-related stressors (Lindsay & Creswell, 2017, p. 
51).  Similarly, Mindfulness-to-Meaning Theory (Garland et al., 2015) suggests that 
acceptance, as a part of mindfulness, is critical to facilitating positive reappraisal which, in 
turn, improves psychological and existential outcomes (e.g., a sense of meaning in life).    
Integrated model of acceptance.  Our integrated model of acceptance of cancer draws 
upon coping theory (Carver et al., 1989; Lazarus & Folkman, 1984; Park, 2010) and third 
wave theories (Garland et al., 2015; Hayes et al., 1994; Kabat-Zinn, 1990; Linehan, 1993; 
Segal et al., 2002).  Broadly, we conceptualize acceptance of cancer as an active willingness 
to be present with cancer-related realities while giving up efforts to judge or control cancer-
related appraisals or feelings.  In addition, acceptance of cancer involves a behavioral 
willingness in response to cancer-related stressors, resulting in action aligned with deeply 
held values (Hayes et al., 1994; J. C. Williams & Lynn, 2010).  Thus, acceptance of cancer is 
a coping strategy that is evidenced by value-based action.  For instance, patients accepting 
early-stage cancer might actively engage in medical decision-making and select treatment 
options based on personal values.  Among patients with terminal cancer, acceptance might 
lead to diverse behavioral outcomes ranging from clinical trial enrollment to seeking hospice 
care.  In all cases, patients would be showing acceptance if their behavioral responses to 
cancer are consistent with their values.  
According to our integrated model, acceptance of cancer is a nonjudgmental and 
compassionate way of relating to internal experiences of the illness, such as appraisals, 
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emotional responses, memories, and bodily sensations.  Acceptance involves letting go of the 
struggle to control these internal experiences while simultaneously embracing the reality of 
the illness.  Thus, our definition of acceptance blends coping and third wave theories by 
acknowledging the central role of appraisals in coping (Lazarus & Folkman, 1984; Park, 
2010) while suggesting that the way cancer patients relate to their appraisals (i.e., degree of 
cognitive fusion) can also lead to distress (Garland et al., 2015; Gillanders et al., 2015; Hayes 
et al., 2006).  In other words, being caught up in the content of distressing thoughts about the 
illness and viewing them as permanent realities may result in additional suffering.  
Conversely, adopting an open, accepting posture towards illness-related thoughts and feelings 
may allow patients to experience this reality with greater ease.  We contend along with third 
wave theorists that acceptance is not an end in itself (Hayes et al., 2006); by accepting the 
illness to a greater degree, patients are empowered to engage in value-based actions, which 
might subsequently improve psychological well-being.  
Present Study: Acceptance of Cancer and Distress   
Consistent with our integrated model of acceptance, studies have shown that greater 
acceptance of cancer is related to reduced symptoms of cancer-specific distress, depression, 
and anxiety; however, effect sizes for these relationships vary from small to large (e.g., Dasch 
et al., 2010; Mack et al., 2008; Peters et al., 2014).  Differences in sample characteristics and 
measures of acceptance across studies may contribute to this variability in effect sizes.  
Certain demographic and medical subgroups of cancer patients might experience greater 
mental health benefits from acceptance.  In addition, it is possible that only some facets of 
acceptance captured by certain measures are strongly correlated with distress. 
 Increasingly, acceptance has been targeted in mindfulness and acceptance-based 
therapies for cancer patients (e.g., ACT for cancer patients: J. Low et al., 2016).  Recent 
reviews suggest that among cancer patients, mindfulness and acceptance-based interventions 
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lead to significant moderate to large improvement in emotional well-being and quality of life 
as well as moderate to large reductions in anxiety and depressive symptoms and traumatic 
stress responses (Fashler et al., 2018; Graham, Gouick, Krahé, & Gillanders, 2016; Haller et 
al., 2017; Hulbert‐ Williams et al., 2015; Zhang et al., 2015; Zimmermann, Burrell, & Jordan, 
2018).  However, few studies have investigated acceptance as a mechanism of change in 
acceptance-based intervention trials with cancer populations (e.g., Hawkes, Pakenham, 
Chambers, Patrao, & Courneya, 2014).  Determining the strength of the relationship between 
acceptance of cancer and distress will provide further evidence of its clinical relevance and 
inform interventions for distressed cancer patients.  Therefore, guided by our integrated model 
of acceptance, we conducted the first meta-analyses to examine the average strength of 
relationships between acceptance of cancer and (1) general distress; (2) cancer-specific 
distress (i.e., fear of recurrence and cancer-related PTSD); (3) depressive symptoms; and (4) 
anxiety symptoms among cancer patients.  We also explored potential moderators of these 
associations, all of which had sufficient variance for meta-regression analyses (i.e., age, 
gender, marital status, time since cancer diagnosis, and cancer stage).  Such analyses inform 
clinical practice by elucidating whether certain subgroups might derive greater benefit from 
an acceptance-based intervention.  Based on our findings, we then present a number of 
directions for future research and implications for clinical practice. 
Method 
Literature Search 
This review was conducted in accordance with the Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses (PRISMA) Statement (Moher, Liberati, Tetzlaff, & 
Altman, 2009).  A systematic literature search using CINAHL, Embase, MEDLINE, 
PsycINFO, PsycARTICLES, and Web of Science databases, using combinations of (a) cancer 
and (b) acceptance of cancer related search terms was conducted until August 15, 2018 (see 
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Appendix A for the full list of search terms).  Reference lists and forward citations of selected 
eligible articles were examined to identify any studies that may have been missed in the 
database searches.  Authors of the studies that did not include sufficient information to 
determine study eligibility or conduct statistical analyses were contacted.   
Inclusion and Exclusion Criteria 
 Eligibility criteria were applied in two phases: (1) title and abstract screening, and (2) 
full-text screening.  Eligibility criteria included: (1) examining a sample of adult (18+ years of 
age) cancer patients/survivors; (2) reporting sufficient information to calculate an effect size 
representing a relationship between acceptance of cancer and distress (i.e., an effect size or 
mean, standard deviation, and n); and (3) being written in English.  Eligible records included 
journal articles, books and book chapters, theses and dissertations, brief reports, and 
conference abstracts and presentations.  As part of the inclusion criteria, validated self-report 
measures of acceptance of cancer were selected a priori.  During the database search, 
additional measures were included if they assessed acceptance in line with our conceptual 
definition (i.e., recognizing and staying present with the reality of the diagnosis rather than 
engaging in resignation or fatalism), and if they had acceptable psychometric properties, 
including reliability (i.e., Cronbach’s alpha > .70) and validity evidence (e.g., strong 
correlations with other reliable measures of acceptance).  Similarly, validated self-report 
measures of distress were selected a priori, and additional measures found during the 
database search were included if they had acceptable psychometric properties.  When the 
study sample included multiple disease groups, only information pertaining to cancer 
patients/survivors was included.  When there were multiple records using the same sample, 
peer-reviewed articles and/or the most relevant studies (e.g., records that examined the 
acceptance-distress association in greater detail) were chosen.  Studies were excluded when 
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sufficient information to compute effect sizes was not provided in the text or could not be 
received from the authors.     
Study Selection 
Figure 1 shows a flowchart of study selection.  The first author (ES) screened all of the 
titles and abstracts and, when found eligible, the full-texts; the second author (DBT) screened 
20% of the titles and abstracts and 20% of the full-texts.  Any discrepancies were resolved 
through consensus meetings.  The electronic database search identified 8,449 records.  After 
excluding duplicates and adding 73 records found from other sources (e.g., backwards and 
forwards citation searches), 3,983 records were extracted for title and abstract screening.  A 
total of 3,507 records were excluded with 95.3% agreement between raters (Cohen’s kappa = 
.72).  Thus, 476 records were selected for full-text screening of which 342 records were 
excluded, and 134 were selected for meta-analyses.  There was 92.6% interrater agreement for 
full-text screening (Cohen’s kappa = .79).  Of the 134 records examined for coding, 36 
records included sufficient information for analyses.  We contacted authors of 98 records and 
received sufficient data for 42 records.  Overall, 78 records with sufficient information were 
included in effect size calculations, and the remaining 56 records were excluded due to 
insufficient information for these calculations.  When records reported effect sizes 
individually for each sex or subsample (e.g., individual samples from different sites), these 
were treated as individual samples, resulting in effect sizes from 86 independent samples.  
Each independent sample was coded separately.   
From 75 separate records, we included 83 independent samples in the analysis 
examining the relationship between acceptance of cancer and general distress.  We included 
13 independent samples from 13 records in the analysis examining the relationship between 
acceptance of cancer and cancer-specific distress.  From 41 records, we included 46 
independent samples in the analysis examining the relationship between acceptance of cancer 
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and depressive symptoms, and from 29 records, we included 31 independent samples in the 
analysis examining the relationship between acceptance of cancer and anxiety.   
Coding 
A systematic coding frame was created based on a modified version of Lipsey and 
Wilson’s (2001) example codebook.  For each record, the following information was coded: 
type of record (e.g., journal article, dissertation); year of publication; year of data collection; 
publication status (i.e., published vs. not published); and study design (i.e., cross-sectional, 
longitudinal, case-control, or intervention).  For each sample, the following descriptive 
information was coded: sample size, ethnic composition (i.e., percent White), mean years of 
education, cancer type (e.g., breast, prostate), and country (e.g., country where the data were 
collected).  The following potential moderators were coded: mean age of the sample; gender 
(i.e., percent female); marital status (i.e., percent married/partnered); mean time since 
diagnosis (in years); and advanced stage (i.e., percent with advanced-stage cancer).  
Advanced-stage cancer included: stage III, IV, and metastatic breast cancer, colorectal cancer, 
gynecological cancer, Hodgkin’s lymphoma, non-small cell lung cancer, and prostate cancer; 
stage III and metastatic testicular cancer; and extensive-stage small cell lung cancer (National 
Cancer Institute, 2015).  The first author (ES) conducted the initial coding, and the second 
author (DBT) coded the information reported in 20% of the selected full-texts.  There was 
94.8% interrater agreement for coding (Cohen’s kappa = .89).  Cases of disagreement were 
resolved during consensus meetings.   
Pearson’s product-moment correlation coefficient (r) was used as the main outcome 
metric.  For cross-sectional and case-control studies, acceptance of cancer and general and/or 
cancer-specific distress correlation coefficients were extracted.  For longitudinal and 
intervention studies, only the initial (or baseline) acceptance of cancer and general and/or 
cancer-specific distress correlation coefficients were extracted in order to include the largest 
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possible sample and minimize the effects of extraneous factors (e.g., intervention, practice 
effects).  All of the extracted correlation coefficients were weighted by sample size to 
compute the overall study effect sizes.   
Quality Assessment  
The quality of study reporting was assessed using the Strengthening the Reporting of 
Observational Studies in Epidemiology (STROBE) guidelines (von Elm, Altman, & Egger, 
2008).  The first author (ES) assessed reporting quality for all of the records, and the second 
author (DBT) assessed the reporting quality of 20% of the records. The interrater agreement 
for study reporting quality was 91.4% (Cohen’s kappa = .81).  Disagreements were resolved 
during consensus meetings.   
Meta-analytic Method 
 Four separate meta-analyses were conducted examining the relationships between 
acceptance of cancer and (1) general distress (i.e., distress, depressive and anxiety symptoms, 
reduced mental health and emotional well-being); (2) cancer-specific distress (i.e., fear of 
recurrence and cancer-related PTSD); (3) depressive symptoms; and (4) anxiety symptoms.  
General distress was examined separately because some measures of distress do not 
differentiate between depressive and anxiety symptoms and only provide information about 
global distress or general emotional/mental health.  Separate meta-analyses for depressive and 
anxiety symptoms were conducted due to their prevalence in cancer patients and associations 
with important health outcomes (L. F. Brown et al., 2010; Lin et al., 2017; Pinquart & 
Duberstein, 2010).  When studies reported multiple effect sizes from the same sample, these 
effect sizes were aggregated using the MAc package available in R, which accounts for the 
dependencies among within-study effect sizes (Hunter & Schimdt, 2004).   
All data were coded in SPSS (version 24.0) and analyzed using MAc and metafor 
packages in R v.3.4.0 (R Core Team, 2013).  Raw correlations were converted to the Fisher’s 
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Z scale to stabilize the variance, and analyses were performed using the transformed values 
(Hedges & Olkin, 1985).  Summary statistics of Fisher’s Z-transformed values and their 95% 
confidence intervals (CIs) were converted back to the r metric (Schulze, 2004) using an 
integral z-to-r transformation for ease of interpretation. 
 Meta-analyses were conducted using random-effects models with restricted maximum 
likelihood estimators (Viechtbauer, 2005).  Random-effects models were chosen as they 
compute less biased and more conservative estimated effect sizes compared to fixed-effects 
models (Card, 2011).  In accordance with Hunter and Schmidt (2004), meta-analyses were 
conducted with raw correlations (r) and correlations corrected for measurement reliability (ρ).  
When reliability coefficients were not reported in the study, the median reliability coefficients 
of the measures were imputed based on those reported in the sample.  For single-item 
measures, a reliability coefficient of .60 was imputed (Hunter & Schimdt, 2004; Sharma & 
Yetton, 2007).  Effect sizes were considered statistically significant for p-values < .05.   
Following the computation of the mean effect size, heterogeneity of effect sizes was described 
using Cochrane Q, I,² and Tau² (τ²) statistics.  Potential moderators were examined when 
significant heterogeneity was present, as demonstrated by an I² ≥ 25%, a τ² > 0, and a 
significant Q-statistic (Borenstein, Hedges, Higgins, & Rothstein, 2011).  Effects of potential 
moderators, such as age, gender, marital status, time since diagnosis, and stage of cancer, 
were examined with meta-regression analyses using a restricted maximum likelihood model.  
Each moderator was examined independently in order to maximize the number of studies 
included in the analyses.   
To identify potential publication bias, Begg’s funnel plots (Begg & Mazumdar, 1994) 
with Duval and Tweedie’s (2000) trim-and-fill adjustment were created and inspected 
visually as well as with Egger’s test of asymmetry and Begg’s rank test (Begg & Mazumdar, 
1994; Sterne & Egger, 2006).  In addition, Orwin’s Fail-safe N was calculated to estimate the 
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number of studies with an effect size of zero (r = .00) that would be required to reduce the 
mean effect size across studies to a specified inconsequential level (i.e., a non-significant 
effect size) (Lipsey & Wilson, 2001).  Finally, meta-regression analyses were conducted 
examining publication status (i.e., published vs. not published), year of data collection, and 
study reporting quality as potential moderators.  
Results 
Characteristics of the Studies  
Of the 78 records included, 43 were cross-sectional, 26 were longitudinal, two were 
case-control, and seven were intervention studies.  The mean sample size of the included 
studies was 179.62 (SD = 211.20; range = 12-1,280).  The mean age of the samples was 55.75 
(SD = 8.52; range = 25.00-73.30; k = 68).  Concerning gender, 32 studies included a mixed 
sample; 36 studies included a female sample; six studies included a male sample; and four 
studies did not report the gender of the sample.  The mean percentage of females across 
studies was 71.13% (SD = 33.43%; k = 74).  The mean percentage of Caucasians across 
studies was 78.09% (SD = 27.84%; range = 0.00-100.00; k = 51).  The mean percentage of 
participants who were married or partnered was 71.61% (SD =15.92%; range = 31.37-100.00; 
k = 56).  The mean time since diagnosis was 2.16 years (SD = 1.78; range = 0.01-8.46; k = 
28).  The mean percentage of participants with advanced-stage cancer (e.g., stage III, IV, or 
metastatic) was 25.87% (SD = 25.40%; range = 0.00-100.00; k = 41).  The majority of studies 
included samples of mixed cancer patients (29.49%, 23/78) or breast cancer patients (41.03%, 
32/78).  Appendix B provides additional information about the studies included in the meta-
analyses. 
Study Reporting Quality 
The mean study reporting quality rating based on the STROBE criteria was 73.29% 
(SD = 8.99%; range = 57.14-93.10).  The majority of studies fulfilled over 60% of the 
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STROBE criteria.  Almost all studies provided adequate information about the scientific 
background, specified their hypotheses, described measures and methods of main analyses, 
and discussed study limitations.  However, several prevalent weaknesses in reporting methods 
and results were identified.  For example, a small minority of studies reported how sample 
size was determined (reported in 5.13%, 4/78), reasons for non-participation (23.08%, 18/78), 
and methods of dealing with missing data (17.95%, 14/78).  Appendix C provides additional 
information about study reporting quality.     
Mean Effect Sizes 
Table 1 presents the mean effect sizes that were calculated for the relationships 
between acceptance of cancer and (1) general distress, (2) cancer-specific distress, (3) 
depressive symptoms, and (4) anxiety symptoms.  Appendix D presents the forest plots 
depicting the mean effect sizes for each study and the 95% CIs for the effect sizes.  We found 
small to moderate, negative, and statistically significant mean effect sizes for the relationships 
between acceptance of cancer and general distress (r = -.31, p < .0001), cancer-specific 
distress (r = -.18, p < .0001), depressive symptoms (r = -.25, p < .0001), and anxiety 
symptoms (r = -.22, p < .0001).  Based on stem-and-leaf plots, one study (Lyons et al., 2015) 
was identified as an outlier for the association between acceptance of cancer and depressive 
symptoms.  Sensitivity analyses conducted excluding this study did not yield statistically 
significant differences in the results; thus, the study was included in the final analyses (Lipsey 
& Wilson, 2001).   
Moderator Analyses 
Heterogeneity analyses demonstrated significant between-study variance in the 
relationships between acceptance of cancer and general distress (Q = 873.24; I2 = .91; τ² = 
.06), depressive symptoms (Q = 370.98; I2 = .87; τ² = .04), and anxiety symptoms (Q = 
206.82; I2 = .86; τ² = .04); thus, we conducted moderation analyses for these associations.  
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However, there was minimal heterogeneity in the relationship between acceptance of cancer 
and cancer-specific distress (Q = 12.76; I2 = .00; τ² = .00); therefore, we did not conduct 
moderation analyses for this association.  Table 2 presents the results of the meta-regression 
analyses examining the five moderators.   
Age.  Patients’ age was a significant moderator of the relationship between acceptance 
of cancer and depressive symptoms.  We found that for every one year increase in age, the 
relationship between acceptance of cancer and depressive symptoms strengthened by 0.010 (b 
= -.010, SE = .005, z = -2.10, 95% CI -.019 to -.001; k = 34).  However, age did not 
significantly moderate associations between acceptance of cancer and general distress (b = -
.001, SE = .004, z = -.31, 95% CI -.009 to .006; k = 65) or anxiety symptoms (b = -.007, SE = 
.005, z = -1.30, 95% CI -.017 to .003; k = 26).    
Gender.  Gender did not significantly moderate relationships between acceptance of 
cancer and general distress (b = -.001, SE = .001, z = -1.32, 95% CI -.003 to .001; k = 71), 
depressive symptoms (b = -.002, SE = .001, z = -1.36, 95% CI -.004 to .001; k = 39), or 
anxiety symptoms (b = -.001, SE = .001, z = -.85, 95% CI -.004 to .002; k = 28).   
 Marital status.  Marital status (i.e., percent of patients married/partnered) was a 
significant moderator of the relationships between acceptance of cancer and depressive 
symptoms (b = .007, SE = .003, z = 2.43, 95% CI .001 to .012; k = 26) as well as anxiety 
symptoms (b = .006, SE = .003, z = 2.08, 95% CI .000 to .011; k = 20).  For each percent 
increase in married/partnered patients in the sample, the relationship between acceptance of 
cancer and depressive symptoms weakened by 0.007, and the relationship between acceptance 
of cancer and anxiety symptoms weakened by 0.006.  However, the relationship between 
acceptance of cancer and general distress was not significantly moderated by marital status (b 
= .003, SE = .002, z = 1.55, 95% CI -.001 to .008; k = 53).   
Time since diagnosis.  Time since diagnosis did not significantly moderate the 
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relationships between acceptance of cancer and general distress (b = .036, SE = .023, z = 1.55, 
95% CI -.010 to .082; k = 28), depressive symptoms (b = .047, SE = .025, z = 1.87, 95% CI -
.002 to .097; k = 13), or anxiety symptoms (b = .054, SE = .040, z = 1.37, 95% CI -.023 to 
.131; k = 7).  
Cancer stage.  Cancer stage was a significant moderator of the relationships between 
acceptance of cancer and depressive symptoms (b = .004, SE = .002, z = 2.59, 95% CI .001 to 
.007; k = 18) as well as anxiety symptoms (b = .004, SE = .001, z = 3.40, 95% CI .002 to 
.006; k = 13).  For each percent increase in advanced-stage cancer patients in the sample, 
associations between acceptance of cancer and both depressive and anxiety symptoms 
weakened by 0.004.  However, the relationship between acceptance of cancer and general 
distress was not significantly moderated by cancer stage (b = .000, SE = .002, z = -.21, 95% 
CI -.004 to .003; k = 39). 
Publication Bias 
Publication bias was an unlikely explanation for the relationships between acceptance 
of cancer and general distress (fail-safe N = 183), depressive symptoms (fail-safe N = 73), 
and anxiety (fail-safe N = 40), given the high number of studies with null effects that would 
be required to reduce the effect sizes to inconsequential levels.  Further support for a low 
likelihood of publication bias included symmetrical distribution of the effect sizes in trim-
filled funnel plots (see Appendix E) and non-significant results for Egger’s regression and 
Begg’s rank correlation tests.  For the acceptance of cancer and cancer-specific distress 
association, fail-safe N indicated that only thirteen studies with null effects would be required 
to bring this relationship below a significant level (r = -.10, p > .05).  However, publication 
bias was determined to be unlikely, as the trim-filled funnel plot showed symmetrical 
distribution of the effect sizes and Egger’s regression and Begg’s rank correlation tests were 
non-significant.   
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Additionally, publication status (i.e., published vs. not published), year of data 
collection, and study reporting quality did not significantly moderate the associations between 
acceptance of cancer and general distress (ps = .429, .544, and .059, respectively), cancer-
specific distress (ps = .279, .748, and .667, respectively), depressive symptoms (ps = .235, 
.773, and .342, respectively), or anxiety (ps = .335, .322, and .338, respectively).  
Discussion 
The aims of the current meta-analysis were to estimate associations between 
acceptance of cancer and distress outcomes and examine whether the strength of these 
associations differed by demographic or medical factors.  We found significant, small to 
moderate, negative relationships between acceptance of cancer and general distress, cancer-
specific distress, depressive symptoms, and anxiety symptoms.  These results are consistent 
with our integrated model of acceptance of cancer, which is grounded in coping theory 
(Lazarus & Folkman, 1984) and third wave theories (Hayes et al., 1999; Kabat-Zinn, 1990; 
Linehan, 1993; Segal et al., 2002).  Additionally, age, marital status, and stage of cancer were 
identified as significant moderators of associations between acceptance of cancer and certain 
types of distress.  
 Overall, our findings suggest that acceptance may play a role in reducing cancer 
patients’ psychological distress.  As stated earlier, we conceptualize acceptance of cancer as 
an active process that changes how patients relate to their internal experiences of the illness 
such as appraisals, emotional responses, and bodily sensations.  Specifically, acceptance 
involves taking a nonjudgmental and compassionate stance toward internal experiences, 
thereby reducing the struggle with the realities of the illness.  In addition, we conceptualize 
acceptance as behavioral willingness in response to cancer-related stressors, resulting in 
action consistent with deeply held values.  For example, cancer patients employing 
acceptance-based coping strategies may focus on learning to live with the disease, take an 
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active role in treatment decision-making, or express their thoughts and feelings about the 
disease to loved ones, all of which may reduce distress (Mack et al., 2008).   
Although all of our results were small to moderate effect sizes, acceptance of cancer 
had the smallest association with cancer-specific distress, the largest association with general 
distress, and similar small associations with anxiety and depressive symptoms.  Several 
explanations for these findings warrant mention.  First, most of the included measures of 
cancer-specific distress assessed cancer-related post-traumatic stress symptoms, which tend to 
be endorsed at low levels compared to fear of recurrence and general distress (Abbey et al., 
2015).  Thus, limited variance in cancer-specific distress may have resulted in a small 
correlation with acceptance.  In addition, fewer studies assessed cancer-specific distress 
(k=13) relative to other distress outcomes (ks=29 to 75).  These findings also might be 
partially explained by limitations of acceptance measures (e.g., unitary construct).  For 
instance, current measures do not assess acceptance of cancer-specific stressors, such as the 
prospect of death, changes in physical appearance, and role changes, which may be more 
strongly associated with cancer-specific distress.          
Moderators of the acceptance of cancer and distress relationship 
The current results suggest that acceptance confers greater psychological benefits for 
certain subgroups of cancer patients.   
Age.  Although the relationship between acceptance of cancer and depressive 
symptoms was stronger for older cancer patients, this moderation effect was not significant 
when examining general distress or anxiety.  These findings should be cautiously interpreted, 
as both younger and older adults were underrepresented in the studies.  Acceptance may be an 
important process for older adults as they attain a developmental stage that involves reflection 
on their lives, including fulfilled life goals and regrets.  Alternatively, acceptance may be 
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equally important for adults across the age spectrum as they face a medical reality that 
interferes with important life goals or activities.   
Gender.  Gender did not significantly moderate the relationships between acceptance 
of cancer and general distress, anxiety, or depressive symptoms, suggesting that acceptance 
may be an equally important coping strategy for men and women.   Gender differences in 
acceptance coping have not been consistent across studies (Czerw, Religioni, & Deptala, 
2016; Nowicki et al., 2015).  It is possible that acceptance of different facets of cancer (e.g., 
reduced self-sufficiency, changes in body image) may confer greater mental health benefits 
for certain gender groups.  However, current measures of acceptance are not 
multidimensional, thereby limiting our ability to identify possible gender differences in these 
associations.  Alternatively, our null moderation findings for gender may be due to the limited 
representation of male cancer patients in the analyses.  
Marital status.  Acceptance of cancer was more strongly correlated with depressive 
and anxiety symptoms among cancer patients without a spouse or partner.  Marital status can 
be considered a proxy variable for enhanced social support, which appears to influence 
patients’ choice of coping strategies (Holland & Holahan, 2003; Kim, Han, Shaw, McTavish, 
& Gustafson, 2010) and, in turn, influence distress. When partner support is absent, coping 
strategies such as acceptance might be more important for reducing distress.  However, the 
present findings were not entirely consistent, as marital status did not moderate the acceptance 
of cancer-general distress relationship.  Our mixed findings might reflect the variable quality 
of marital relationships, as being in an unsatisfying marriage might undermine mental health 
to a greater extent than being single or divorced (Thomas, Liu, & Umberson, 2017; K. 
Williams, 2003).    
Time since diagnosis.  Time since diagnosis did not significantly moderate the 
relationships between acceptance of cancer and general distress, anxiety, or depressive 
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symptoms, suggesting that acceptance may be equally important at different phases of the 
cancer trajectory.  As patients cope with initial diagnosis, or different phases of treatment or 
end-of-life care, acceptance may play a critical role in regulating emotions.  Future 
longitudinal research should examined this hypothesis at different phases of the cancer 
trajectory.  Additionally, information regarding time since diagnosis was limited and long-
term cancer survivors were underrepresented in our analyses.   
Stage of cancer.  Acceptance of cancer was more strongly correlated with depressive 
and anxiety symptoms among cancer patients with early-stage disease; however, this finding 
was not replicated when examining general distress.  As advanced-stage cancer patients were 
underrepresented in the analyses, the results should be interpreted with caution.  Additionally, 
given that many cancer patients do not have an accurate perception of their disease stage 
(Applebaum et al., 2014), stage of cancer as identified from medical charts might not be an 
appropriate proxy variable for patients’ understanding of their prognosis.   
Limitations  
 Limitations of included studies should be noted.  First, most of the studies were 
conducted in the United States, and the majority of participants were married middle-aged 
Caucasian women.  In addition, most participants were diagnosed with early-stage cancers 
within the past 5 years.  Given the current variance in sample characteristics, we only 
examined five demographic and medical variables as potential moderators.  Future studies 
should explore other possible moderators (e.g., cancer type, comorbid medical conditions) in 
more diverse samples.  Also, certain demographics or medical information were not reported 
in some studies, which led to reduced statistical power for a subset of the moderation 
analyses.  The measurement of acceptance is another limitation, with all studies assessing it as 
a unitary construct that does not include all aspects of our conceptual definition.  We contend 
that acceptance of cancer may be a multifaceted construct (e.g., acceptance of death, changes 
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in physical appearance, reduced self-sufficiency).  Therefore, measure development is 
required in order to identify potentially distinct associations of acceptance facets with distress 
and determine if these associations differ by gender or other moderating factors.  
Additionally, few authors using the COPE or Brief COPE reported whether the instructions 
were revised to refer to acceptance of cancer-specific stressors.  However, it is likely that 
many patients considered their cancer experience when completing these measures, as the 
original instructions focus on coping with stressful life events.    
Other study design and reporting issues warrant attention.  First, in order to maximize 
the sample sizes and reduce the impact of third variables, all of our analyses were based on 
baseline correlational data.  Thus, we cannot infer directionality and change over time in the 
acceptance of cancer-distress relationships.  It is possible that increased acceptance is a result 
of reductions in distress, a hypothesis that may be tested in future longitudinal investigations.  
Additionally, as in prior reviews, our analysis of study reporting quality showed that many 
researchers did not report information such as the determination of sample size or reasons for 
non-participation, thereby lowering their reporting quality and limiting our ability to evaluate 
their research procedures.  Even though moderation analyses for study reporting quality did 
not suggest that this was a significant concern, greater transparency in study reporting would 
improve readers’ ability to evaluate findings.  Finally, as in previous reviews, our meta-
analytic results may be affected by publication bias (i.e., the file drawer problem).  However, 
we attempted to minimize this limitation by including unpublished results (e.g., dissertations, 
conference abstracts), and analyses of publication bias suggested that this was not a 
significant concern.  
Directions for Future Research 
Measurement of acceptance of cancer.  Current measures do not assess certain 
aspects of acceptance (e.g., behavioral willingness) and acceptance of specific cancer-related 
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stressors (e.g., role changes).  Multifaceted measures of acceptance are needed that 
incorporate patients’ perspectives through cognitive interviewing.  Developing behavioral 
indices of acceptance focused on value-based action related to the cancer experience (e.g., 
adherence to goal-concordant medical care) would advance intervention research.   
 Acceptance in relation to attention monitoring and cognitive appraisal.  According 
to Monitor and Acceptance Theory (MAT) (Lindsay & Creswell, 2017), acceptance and 
attention monitoring skills together explain how mindfulness leads to reduced distress, raising 
the question as to whether acceptance without attention monitoring is sufficient for improving 
psychological outcomes.  As none of the studies included in our meta-analyses measured 
attention monitoring, future research should test this hypothesis.   
Additionally, some theorists contend that as part of mindfulness, acceptance has a 
critical role in promoting positive reappraisal (i.e., mentally reconstructing the illness and 
related stressors as meaningful or growth promoting), which confers mental health benefits 
(Garland et al., 2015; Garland et al., 2010).  Although greater acceptance is correlated with 
more positive reappraisal in cancer patients (e.g., Bright & Stanton, 2018), the directionality 
of this relationship should be tested.  Alternatively, acceptance might initially require 
cognitive control or nonappraisal in order to overcome habitual emotional reactivity (Y. Y. 
Tang, Hölzel, & Posner, 2015), and over time, cognitive control efforts may not be required to 
facilitate acceptance.  Research is needed to test these hypotheses. 
Acceptance and positive psychological outcomes.  Positive psychological outcomes 
(e.g., meaning in life, benefit finding, posttraumatic growth, courage, self-compassion, value 
clarification, positive emotions) in relation to acceptance of cancer have received less 
attention (Butts & Gutierrez, 2018; Garland et al., 2015; Garland et al., 2010; Gilbert & 
Choden, 2014; Hayes et al., 2006; Park, 2010).  While Park (2010) contended that acceptance 
of a stressor is an outcome of the meaning-making process, acceptance may also be part of an 
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active meaning-making process (Garland et al., 2017), leading to more effective meanings-
made or growth, and, in turn, reducing distress.  Acceptance can also be conceptualized as a 
profound act of courage and self-compassion (Gilbert & Choden, 2014; Neff, 2003).  
Research is needed to test these competing conceptualizations of acceptance. 
Acceptance of cancer in a medical context.  In a cancer context, acceptance involves 
acknowledging one’s disease stage, prognosis, and available treatment options.  However, up 
to 75% of cancer patients do not have an accurate understanding of their disease stage or 
prognosis (Applebaum et al., 2014), which may, in part, reflect a lack of acceptance.   
Additionally, acceptance of cancer might impact patients’ engagement in medical decision-
making.  For example, patients with greater acceptance of their advanced cancer might be 
more willing to have end-of-life discussions, which may result in higher rates of advance care 
planning and enrollment in hospice compared to patients with less acceptance.  Longitudinal 
studies are needed to investigate the potential predictive value of acceptance in medical 
decision-making while taking into account patients’ prognostic awareness and their values.  
Acceptance of cancer in a social and cultural context.  Most cancer patients have a 
primary family caregiver who shares the psychosocial burden of the illness.  Caregiver 
support may facilitate patient acceptance through enhanced emotional and cognitive 
processing of cancer information and meaning-making.  Additionally, the majority of studies 
on acceptance of cancer have been conducted in the United States, and few studies have 
included information on patients’ and caregivers’ religious or spiritual beliefs and practices.  
Future cross-cultural studies are needed, as the meaning of acceptance of cancer for patients 
and caregivers depends on cultural and religious worldviews.   
Implications for Clinical Practice and Intervention Research 
Our findings have a number of implications for clinical practice and intervention 
research.  First, our results contribute to a growing body of research suggesting that 
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interventions fostering acceptance in cancer patients might improve mental health outcomes 
(Hulbert‐ Williams et al., 2015; Zhang et al., 2015).  Reviews examining the effects of 
MBCT and MBSR in cancer patients showed moderate to large effects on anxiety and 
depressive symptoms (ds = .28 to .90) (Haller et al., 2017; Zhang et al., 2015).  Additionally, 
pilot findings suggest that ACT leads to significant improvement in acceptance and reductions 
in distress outcomes in cancer patients (Fashler et al., 2018; Hulbert‐ Williams et al., 2015).  
Overall, our findings in combination with these trial results suggest that acceptance of cancer-
related experiences might be targeted in interventions aiming to improve mental health in 
cancer patients.  As the evidence for mindfulness-based interventions grows, clinicians have 
effectively disseminated them in cancer centers and cancer support groups (Shennan, Payne, 
& Fenlon, 2011). 
Our findings also tentatively suggest that acceptance of cancer may benefit a number 
of patient subgroups (e.g., men and women, patients at different periods since diagnosis).  
However, a number of our moderation findings were mixed and limited by the small sample 
sizes for certain subgroups.  Thus, recommendations regarding the targeting or tailoring of 
acceptance-based interventions to cancer patient subgroups are premature. 
Regarding intervention research, identifying mechanisms of change in mindfulness 
and acceptance-based interventions for cancer patients is an important future direction.  
Recent reviews of studies with primarily healthy adults found promising evidence that 
changes in acceptance, mindfulness, rumination, worry, and self-compassion are potential 
mechanisms underlying the mental health benefits of mindfulness- and acceptance-based 
interventions (Alsubaie et al., 2017; Gu, Strauss, Bond, & Cavanagh, 2015).  In addition, it is 
not clear whether acceptance, mindfulness more broadly (including acceptance and attention 
monitoring), or a combination of the aforementioned variables is the critical mechanism of 
change leading to psychological improvement.  Two recent studies comparing attention 
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monitoring training to acceptance and attention monitoring training in healthy adults found 
that the latter group had greater reductions in distress reactivity (Lindsay, Chin, et al., 2018; 
Lindsay, Young, Smyth, Brown, & Creswell, 2018).  However, the pain literature has 
produced mixed evidence of the mediating role of acceptance in acceptance-based 
interventions (Elvery, Jensen, Ehde, & Day, 2017; McCracken & Gutierrez-Martinez, 2011).  
Future research may examine other potential mechanisms of change in acceptance-based 
interventions with cancer and other medical populations, such as meaning-making, value 
clarification, and value-based action.  Finally, future research could focus on identifying 
therapist behaviors that may promote acceptance of cancer such as processing patients’ 
understanding of their diagnosis and its impact on their life or guiding patients through 
mindfulness exercises.  
Conclusion 
Consistent with our integrated model of acceptance based on coping theory (Lazarus 
& Folkman, 1984) and third wave theories (Hayes et al., 1999; Kabat-Zinn, 1990; Linehan, 
1993; Segal et al., 2002), we found that greater acceptance of cancer was related to reduced 
distress.  We also found preliminary evidence that acceptance of cancer might have a greater 
impact on the mental health of older age groups, singles, and those with early-stage disease.  
Findings suggest that links between acceptance of cancer and psychological outcomes warrant 
further study in mindfulness and acceptance-based intervention trials.  Critical next steps 
include developing multifaceted measures of acceptance of cancer, clarifying the 
directionality of the acceptance-distress relationship, and identifying psychological and social 
processes that facilitate acceptance.  
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Table 1. Mean Effect Sizes for Associations between Acceptance of Cancer and Distress 
Outcomes 
Associati
on  k N r 
S
E 
95
% 
CI 
for 
r Z for r τ² Q I² 
Fail
-
saf
e N 
ρ 
80
% 
CR 
for 
ρ 
Z for  
ρ 
Acceptan
ce of 
7
5 
14,36
8 
-
.3
.0
3 
-
.36, 
-
10.79*
.0
6 
873.24*
** 
.9
1 
183 
-
.4
-
.84, 
-
9.68*
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Note. CI = confidence interval.  CR = credibility interval.  Fail-safe N = Orwin’s Fail-safe N.  
I² = percentage of between-study variability.  k = number of studies.  N = total number of 
participants included in the analysis.  ρ = reliability corrected mean effect size (correlation).   
Q = Cochran’s (1954) Q-statistic of heterogeneity.  r = mean effect size (correlation).  SE = 
standard error.  τ² = estimated variance of the population effect sizes.  Z = z-test for statistical 
significance of the mean effect size.  A z-score greater than the absolute value of 1.96 
indicates statistical significance (Higgins, Thompson, Deeks, & Altman, 2003). 
 
  
cancer - 
general 
distress 
 
1 -
.26 
** 1 .33 ** 
Acceptan
ce of 
cancer - 
cancer-
specific 
distress 
 
1
3 
2,943 
-
.1
8 
.0
2 
-
.21, 
-
.14 
-
9.70**
* 
.0
0 
12.76 
.0
0 
13 
-
.2
2 
-
.31, 
-
.13 
-
9.23*
** 
Acceptan
ce of 
cancer - 
depressiv
e 
symptom
s 
 
4
1 
8,606 
-
.2
5 
.0
3 
-
.31, 
-
.19 
-
7.94**
* 
.0
4 
370.98*
** 
.8
7 
73 
-
.3
3 
-
.73, 
.22 
-
7.58*
** 
Acceptan
ce of 
cancer - 
anxiety 
symptom
s 
 
2
9 
4,974 
-
.2
2 
.0
4 
-
.30, 
-
.15 
-
5.63**
* 
.0
4 
206.82*
** 
.8
6 
40 
-
.2
9 
-
.69, 
.25 
-
5.59*
** 
***p < .001. 
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Table 2. Meta-Regression Analyses Examining Moderators of Associations between 
Acceptance of Cancer and Distress Outcomes 
Moderator Outcome k N I2 R2 B SE 95% 
CI 
Z Q(w) 
Age 
General 
Distress 65 11,622 .91 .00 
-
.001 .004 
-
.009, 
.006  -.31 
724.21*** 
(df = 69) 
 
Depressive 
Symptoms 34  6,099 .83 .11 
-
.010 .005 
-
.019, 
-
.001 -2.10* 
216.60*** 
(df = 36) 
 
Anxiety 
Symptoms 26  3,709 .82 .04 
-
.007 .005 
-
.017, 
.003 -1.30 
130.81*** 
(df = 26) 
           
Gender 
General 
Distress 71 13,306 .91 .00 
-
.001 .001 
-
.003, 
.001 -1.32 
832.24*** 
(df = 76) 
 
Depressive 
Symptoms 39  7,752 .87 .03 
-
.002 .001 
-
.004, 
.001 -1.36 
344.16*** 
(df = 42) 
 
Anxiety 
Symptoms 28  4,503 .85 .00 
-
.001 .001 
-
.004, 
.002  -.85 
185.19*** 
(df = 28) 
           
Marital 
Status General 
Distress 53 10,499 .91 .04 
 
.003 .002 
-
.001, 
.008 1.55 
677.57*** 
(df = 56) 
 
Depressive 
Symptoms 26  5,735 .89 .20 
 
.007 .003 
 
.001, 
.012 2.43* 
239.84*** 
(df = 27) 
 
Anxiety 
Symptoms 20  3,184 .85 .18 
 
.006 .003 
 
.000, 
.011 2.08* 
126.78*** 
(df = 19) 
           
Time 
Since 
Diagnosis 
General 
Distress 28  5,328 .87 .08 
 
.036 .023 
-
.010, 
.082 1.55 
182.55*** 
(df = 28) 
 
Depressive 
Symptoms 13  2,874 .82 .21 
 
.047 .025 
-
.002, 
.097 1.87† 
 53.49*** 
(df = 12) 
 
Anxiety 
Symptoms 7  1,531 .85 .13 
 
.054 .040 
-
.023, 
.131 1.37 
 42.28*** 
(df = 6) 
           
Cancer 
Stage General 
Distress 39  5,818 .90 .00 
 
.000 .002 
-
.004, 
.003 -.21 
363.50*** 
(df = 39) 
 Depressive 18  2,885 .54 .63  .002  2.59**  40.91** 
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Symptoms .004 .001, 
.007 
(df = 16) 
 
Anxiety 
Symptoms 13  1,598 .00 1.00 
 
.004 .001 
 
.002, 
.006 3.40*** 
 12.18 (df 
= 11) 
           
†p < .10; *p < .05; **p < .01; ***p < .001. 
Note.  I² = percentage of between-study variability.  k = number of records included the 
analysis.  N = total number of participants included in the analysis.  Q(w) = the variance 
within group means.  R² = percentage of between-study variability explained by the 
moderator.  SE = standard error.  95% CI = 95% confidence interval for B.  Z = z-test for 
statistical significance of B.  Age = the average age of the sample.  Gender = percent female.  
Marital status = percent married/partnered.  Time since diagnosis = mean time since diagnosis 
in years.  Cancer stage = percent with advanced-stage cancer (e.g., stage III, IV, or 
metastatic).  
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Fig 1. Flow chart of record selection 
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 Integrated model of acceptance of cancer is presented 
 A meta-analytic review of acceptance of cancer and distress relationships  
 Results revealed significant relationships with small-to-moderate effect sizes 
 Age, marital status, and cancer stage were significant moderators 
 Theoretical and clinical implications with future directions are discussed 
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